Cellectis (NASDAQ:CLLS) Trading Up 6.2% - Redmond Register Apr 07, 2020 · Cellectis SA (NASDAQ:CLLS) was up 6.2% on Monday . The stock traded as high as $8.99 and last traded at $8.85, approximately 156,846 shares were traded during trading. An increase of 16% from the average daily volume of 135,652 shares. The stock had previously closed at $8.33. Several analysts have recently issued reports on the […] Predict CLLS - Cellectis Ads Each Repr 1 Ord Spon with ... Predict and forecast CLLS (Cellectis Ads Each Repr 1 Ord Spon) plus see real-time data from other investors. Start making your PredictWallStreet stock market predictions today.
Find the latest Telenav, Inc. (TNAV) stock quote, history, news and other vital information to help you with your stock trading and investing.
Stock Price Forecast. The 14 analysts offering 12-month price forecasts for Cellectis SA have a median target of 32.50, with a high estimate of 73.00 and a low Analyzing Cellectis (NASDAQ:CLLS) stock? View CLLS's stock price, price target , earnings, financials, forecast, insider trades, news, and SEC filings at Based on 6 Wall Street analysts offering stock ratings for Cellectis SA in the last 3 months (by analysts ranked 0 to 5 stars). All Analysts. Top Analysts Cellectis Stock Price Forecast, CLLS stock price prediction. The best long-term & short-term Cellectis share price prognosis for 2020, 2021, 2022, 2023, 2024,
Clean Energy Fuels Corp, CLNE:NSQ forecasts - FT.com
Cellectis S.a. - CLLS - Stock Price Today - Zacks View Cellectis S.A. CLLS investment & stock information. Get the latest Cellectis S.A. CLLS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. CLLS Price Target | Cellectis SA Stock Forecast & Ratings See Cellectis SA price target based on 6 analysts offering 12 month price targets for Cellectis SA in the last 3 months. The average price target is $25.25 with a high forecast of $39.00 and a low forecast of $11.00. The average price target represents a 207.55% increase from the last price of $8.21. CLLS | Cellectis S.A. ADR Overview | MarketWatch What Makes Cellectis S.A. (CLLS) a New Strong Buy Stock Cellectis S.A. (CLLS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects Cellectis S.A. American Depositary Shares (CLLS) Earnings ...
Stock Reversals is stock advisory and market forecasting service. From swing trading strategies and 3x ETF advice to sector analysis our subscription service provides info about individual trades, market corrections or trends.
17 Mar 2020 Stock Market Quotes, Business News, Financial News, Trading Ideas, and For 2020, the company forecast Firdapse net revenues of $135 Foundation Medicine Inc(NASDAQ: FMI) stock delivered outstanding returns of over Oppenheimer forecasts over CVS Health Corporation, updates and deep Why Cellectis SA (ADR)(NASDAQ: CLLS) stock is going gangbusters today. ABBV Price Forecast Based on Dividend Discount Model In comparison to other stocks in the Healthcare sector, AbbVie Inc offers a higher dividend yield than 95.52% of them. In terms of 19, CLLS · Cellectis S.A., 0.00%. 20, MIST 27 Mar 2020 The stock's free cash flow/dividend ratio, potentially useful for understanding its ability to make dividend payments, comes in at -5.26 ZTS Price Forecast Based on Dividend Discount Model 19, CLLS · Cellectis S.A., 0.00%.
Mar 13, 2020 · View detailed financial information, real-time news, videos, quotes and analysis on Cellectis SA (NASDAQ:CLLS). Explore commentary on Cellectis SA …
Find the latest Telenav, Inc. (TNAV) stock quote, history, news and other vital information to help you with your stock trading and investing. Akoustis Technologies, Inc. Common Stock (AKTS) Earnings ... Akoustis Technologies, Inc. is estimated to report earnings on 05/08/2020. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. CRBP - Corbus Pharmaceuticals Holdings Inc Stock quote ... Find real-time CRBP - Corbus Pharmaceuticals Holdings Inc stock quotes, company profile, news and forecasts from CNN Business. CLLS - Cellectis S.A. ADR Stock Price - Barchart.com 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share.